Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and Anaesthetic
Background: This study aimed to evaluate mydriasis stability during cataract surgery in patients with systemic comorbidities such as diabetes mellitus (DM) and pseudoexfoliation syndrome (PXF) after a standardised combination of intracameral mydriatics and anaesthetic (SCIMA). Stable mydriasis is cr...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/15/1/119 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832588111941468160 |
|---|---|
| author | Joanna Dereń-Szumełda Mariola Dorecka Mirosław Dereń Ewa Mrukwa-Kominek |
| author_facet | Joanna Dereń-Szumełda Mariola Dorecka Mirosław Dereń Ewa Mrukwa-Kominek |
| author_sort | Joanna Dereń-Szumełda |
| collection | DOAJ |
| description | Background: This study aimed to evaluate mydriasis stability during cataract surgery in patients with systemic comorbidities such as diabetes mellitus (DM) and pseudoexfoliation syndrome (PXF) after a standardised combination of intracameral mydriatics and anaesthetic (SCIMA). Stable mydriasis is crucial for safe and effective phacoemulsification. Methods: Patients were included if they achieved pupil dilation ≥6.0 mm during the qualifying visit. A total of 103 patients were enrolled, divided into three groups: cataract with diabetes (C + DM group, <i>n</i> = 35), cataract with PXF (C + PXF group, <i>n</i> = 32), and cataract without those comorbidities (C group, <i>n</i> = 36). SCIMA was administered, and pupil diameters were measured at key surgical stages. Stability was defined as a pupil diameter of ≥6.0 mm without additional pharmacological intervention and no significant change in its diameter (≥3.0 mm). Results: Stable mydriasis was achieved in 90.3% of patients: 97.1% in the C + DM group, 90.6% in the C + PXF group, and 83.3% in the C group, with no statistically significant differences (<i>p</i> = 0.14). Conclusions: SCIMA effectively maintains mydriasis stability during cataract surgery, even in patients with systemic comorbidities, ensuring greater surgical safety. |
| format | Article |
| id | doaj-art-19d2d028f97a453e9a6221de3554993e |
| institution | Kabale University |
| issn | 2075-1729 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj-art-19d2d028f97a453e9a6221de3554993e2025-01-24T13:38:52ZengMDPI AGLife2075-17292025-01-0115111910.3390/life15010119Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and AnaestheticJoanna Dereń-Szumełda0Mariola Dorecka1Mirosław Dereń2Ewa Mrukwa-Kominek3Ophthalmology Clinic, Military Institute of Aviation Medicine, 01-755 Warsaw, PolandUniversity Clinical Centre named after Prof. K. Gibiński, Medical University of Silesia, 40-514 Katowice, PolandDepartment of Psychophysiological Measurements and Human Factors Research, Research and Development Center, Military Institute of Aviation Medicine, 01-755 Warsaw, PolandUniversity Clinical Centre named after Prof. K. Gibiński, Medical University of Silesia, 40-514 Katowice, PolandBackground: This study aimed to evaluate mydriasis stability during cataract surgery in patients with systemic comorbidities such as diabetes mellitus (DM) and pseudoexfoliation syndrome (PXF) after a standardised combination of intracameral mydriatics and anaesthetic (SCIMA). Stable mydriasis is crucial for safe and effective phacoemulsification. Methods: Patients were included if they achieved pupil dilation ≥6.0 mm during the qualifying visit. A total of 103 patients were enrolled, divided into three groups: cataract with diabetes (C + DM group, <i>n</i> = 35), cataract with PXF (C + PXF group, <i>n</i> = 32), and cataract without those comorbidities (C group, <i>n</i> = 36). SCIMA was administered, and pupil diameters were measured at key surgical stages. Stability was defined as a pupil diameter of ≥6.0 mm without additional pharmacological intervention and no significant change in its diameter (≥3.0 mm). Results: Stable mydriasis was achieved in 90.3% of patients: 97.1% in the C + DM group, 90.6% in the C + PXF group, and 83.3% in the C group, with no statistically significant differences (<i>p</i> = 0.14). Conclusions: SCIMA effectively maintains mydriasis stability during cataract surgery, even in patients with systemic comorbidities, ensuring greater surgical safety.https://www.mdpi.com/2075-1729/15/1/119mydriasis stabilitycataractmydriasisdiabetespseudoexfoliation syndrome |
| spellingShingle | Joanna Dereń-Szumełda Mariola Dorecka Mirosław Dereń Ewa Mrukwa-Kominek Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and Anaesthetic Life mydriasis stability cataract mydriasis diabetes pseudoexfoliation syndrome |
| title | Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and Anaesthetic |
| title_full | Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and Anaesthetic |
| title_fullStr | Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and Anaesthetic |
| title_full_unstemmed | Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and Anaesthetic |
| title_short | Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and Anaesthetic |
| title_sort | mydriasis stability during cataract surgery in patients with systemic comorbidities using a standardised combination of intracameral mydriatics and anaesthetic |
| topic | mydriasis stability cataract mydriasis diabetes pseudoexfoliation syndrome |
| url | https://www.mdpi.com/2075-1729/15/1/119 |
| work_keys_str_mv | AT joannaderenszumełda mydriasisstabilityduringcataractsurgeryinpatientswithsystemiccomorbiditiesusingastandardisedcombinationofintracameralmydriaticsandanaesthetic AT marioladorecka mydriasisstabilityduringcataractsurgeryinpatientswithsystemiccomorbiditiesusingastandardisedcombinationofintracameralmydriaticsandanaesthetic AT mirosławderen mydriasisstabilityduringcataractsurgeryinpatientswithsystemiccomorbiditiesusingastandardisedcombinationofintracameralmydriaticsandanaesthetic AT ewamrukwakominek mydriasisstabilityduringcataractsurgeryinpatientswithsystemiccomorbiditiesusingastandardisedcombinationofintracameralmydriaticsandanaesthetic |